Role of consolidation therapy in transplant eligible multiple myeloma patients.
about
Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practicePhase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma.Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trialsSingle-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation in multiple myeloma: a meta-analysis of randomized controlled trialsInverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma.
P2860
Role of consolidation therapy in transplant eligible multiple myeloma patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of consolidation therapy in transplant eligible multiple myeloma patients.
@en
type
label
Role of consolidation therapy in transplant eligible multiple myeloma patients.
@en
prefLabel
Role of consolidation therapy in transplant eligible multiple myeloma patients.
@en
P2093
P50
P1433
P1476
Role of consolidation therapy in transplant eligible multiple myeloma patients.
@en
P2093
B A Zannetti
P Tacchetti
P304
P356
10.1053/J.SEMINONCOL.2013.07.001
P577
2013-10-01T00:00:00Z